treatment options in post-docetaxel prostate cancer, part i
Published 11 years ago • 469 plays • Length 6:13Download video MP4
Download video MP3
Similar videos
-
5:42
treatments for post-docetaxel prostate cancer, part ii
-
0:48
dr. kantoff on evolving role of docetaxel in prostate cancer treatment
-
4:15
docetaxel in metastatic prostate cancer
-
4:52
docetaxel in non-metastatic prostate cancer
-
1:17
dr. oh on the safety profile of docetaxel in prostate cancer
-
6:43
reimbursement and operational issues in the treatment of prostate cancer, part i
-
6:42
immunotherapy in castration-resistant prostate cancer, part i
-
3:13
treatment options in metastatic prostate cancer
-
6:16
evolution of treatment for metastatic castration-resistant prostate cancer
-
10:36
therapeutic options for advanced prostate cancer
-
1:47
dr. oh on remaining challenges with docetaxel in prostate cancer
-
8:26
new treatment options for advanced prostate cancer
-
11:07
new treatment options in metastatic prostate cancer
-
55:35
is there still a role for docetaxel in mhspc?
-
5:16
exciting advances in systemic therapy for prostate cancer: docetaxel and abiraterone
-
10:55
emerging therapies for advanced prostate cancer
-
5:22
standard of care in metastatic prostate cancer
-
8:21
ep. 10: how has the mcrpc treatment landscape changed?
-
0:45
dr. hahn on patients with prostate cancer whom neither docetaxel or abiraterone is an option